Cargando…
Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India
BACKGROUND: There is growing concern that interferon-γ release assays (IGRAs) are being used off-label for the diagnosis of active tuberculosis (TB) disease in many high-burden settings, including India, where the background prevalence of latent TB infection is high. We analyzed the costs and conseq...
Autores principales: | Little, Kristen M., Pai, Madhukar, Dowdy, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412573/ https://www.ncbi.nlm.nih.gov/pubmed/25918999 http://dx.doi.org/10.1371/journal.pone.0124525 |
Ejemplares similares
-
Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis
por: Dowdy, David W., et al.
Publicado: (2011) -
Clinical value of interferon-γ release assay in the diagnosis of active tuberculosis
por: Ai, Lu, et al.
Publicado: (2019) -
Serological tests for the diagnosis of active tuberculosis: relevance for India
por: Steingart, Karen R., et al.
Publicado: (2012) -
Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California
por: Kay, Alexander, et al.
Publicado: (2017) -
Feasibility of the Interferon-γ Release Assay for the Diagnosis of Genitourinary Tuberculosis in an Endemic Area
por: Kim, Jong Keun, et al.
Publicado: (2013)